相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route
Sonal Patel et al.
JOURNAL OF DRUG TARGETING (2011)
Subchronic administration of rosmarinic acid, a natural prolyl oligopeptidase inhibitor, enhances cognitive performances
Dong Hyun Park et al.
FITOTERAPIA (2010)
Nutraceutical Antioxidants as Novel Neuroprotective Agents
Natalie A. Kelsey et al.
MOLECULES (2010)
Clovamide and rosmarinic acid induce neuroprotective effects in in vitro models of neuronal death
S. Fallarini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Rosmarinic Acid Inhibits 6-OHDA-induced Neurotoxicity by Anti-oxidation in MES23.5 Cells
Pei Ren et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2009)
Effect of caffeic acid and rofecoxib and their combination against intrastriatal quinolinic acid induced oxidative damage, mitochondrial and histological alterations in rats
Harikesh Kalonia et al.
INFLAMMOPHARMACOLOGY (2009)
Rosmarinic acid protects human dopaminergic neuronal cells against hydrogen peroxide-induced apoptosis
Hyo Jung Lee et al.
TOXICOLOGY (2008)
Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms
P. Kumar et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2007)
Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles
K. Vivek et al.
AAPS PHARMSCITECH (2007)
Structural investigations on lipid nanoparticles containing high amounts of lecithin
MA Schubert et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Tryptophan metabolism and oxidative stress in patients with Huntington's disease
N Stoy et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles
V Venkateswarlu et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease
WT Lee et al.
PROGRESS IN NEUROBIOLOGY (2004)
The thalamostriatal system: a highly specific network of the basal ganglia circuitry
Y Smith et al.
TRENDS IN NEUROSCIENCES (2004)
Experimental therapeutics in transgenic mouse models of Huntington's disease
MF Beal et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease
E Saulle et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2004)
In vivo calpain/caspase cross-talk during 3-nitropropionic acid-induced striatal degeneration -: Implication of a calpain-mediated cleavage of active caspase-3
N Bizat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Huntington's disease: a synaptopathy?
JY Li et al.
TRENDS IN MOLECULAR MEDICINE (2003)
Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study
N Pavese et al.
BRAIN (2003)
Preparation and characterization of camptothecin solid lipid nanoparticles
SC Yang et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2002)
Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages
N Schöler et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)
Behavioural correlates of striatal glial fibrillary acidic protein in the 3-nitropropionic acid rat model: Disturbed walking pattern and spatial orientation
CE Teunissen et al.
NEUROSCIENCE (2001)
Mechanisms underlying neural cell death in neurodegenerative diseases: alterations of a developmentally-mediated cellular rheostat
MF Mehler et al.
TRENDS IN NEUROSCIENCES (2000)
Preparation and characterization of solid lipid nanospheres containing paclitaxel
R Cavalli et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2000)
分享论文
